Intracardiac Flow Remodeling in Athletes

NCT ID: NCT03076788

Last Updated: 2024-02-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-01

Study Completion Date

2019-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The uncertainty concerning the onset and the extent of cardiac remodeling in response to intensive training hinders medical evaluation by physician. A better knowledge of the physiology of cardiac adaptation to training will enable physicians to correctly determine whether observed patterns of cardiac remodeling are physiological or pathological. This prospective study proposes to assess in a trained-athlete population the cardiac remodeling in response to intensive exercise training. This study is observational, we do not interfere with athlete's training.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Remodeling, Ventricular

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Athletes

Professional and amateur athletes examined during the medical follow-up at the medical sport centre of Caen University Hospital.

The medical examination consists in a clinical exam, an electrocardiogram and an echocardiography.

electrocardiogram and echocardiography

Intervention Type OTHER

We retrieved all electrocardiograms and echocardiography made during the clinical examination of each athlete and each sedentary control.

* Standard 12 lead ECG
* Trans-thoracic echocardiography examination of cardiac function, morphology and intracardiac flow.

Sedentary controls

Sedentary patients assessed in the cardiology unit with a normal heart function.

The medical examination consists in a clinical exam, an electrocardiogram and an echocardiography.

electrocardiogram and echocardiography

Intervention Type OTHER

We retrieved all electrocardiograms and echocardiography made during the clinical examination of each athlete and each sedentary control.

* Standard 12 lead ECG
* Trans-thoracic echocardiography examination of cardiac function, morphology and intracardiac flow.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

electrocardiogram and echocardiography

We retrieved all electrocardiograms and echocardiography made during the clinical examination of each athlete and each sedentary control.

* Standard 12 lead ECG
* Trans-thoracic echocardiography examination of cardiac function, morphology and intracardiac flow.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18yrs old
* Ability to give written consent for participating in the study

Exclusion Criteria

* Age \< 18yrs old
* Cardiac diseases, arterial hypertension, cardiac devices, diabetes, renal, liver or pulmonary failure
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Caen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amir HODZIC

Medical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de CAEN

Caen, Normandy, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

16-022.

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Coronary Arterial Microcirculation and Metabolism
NCT07074847 ENROLLING_BY_INVITATION